Dr.ObesityLA said:KevinCompounds said: ...we don't know the long-term effects of cardiovascular risk...
6 month update on cardiovascular risk: down 39 lbs, off blood pressure meds, A1C normalized. Genuinely life-changing.
GenomicsKate said:NNT calculation for cardiovascular risk clinical endpoints: NNT = 1/ARR (absolute risk reduction).
That reframing is the part I needed. Printing the relevant bit and taking it with me.
Dr.ObesityLA said:KevinCompounds said: ...we don't know the long-term effects of cardiovascular risk...
Vitamin deficiency cascade with cardiovascular risk: after 6+ months of reduced food intake, I developed a subtle but important pattern: low B12 → elevated homocysteine → increased cardiovascular risk marker.
The connection: B12 is a cofactor for homocysteine metabolism. Without adequate B12, homocysteine accumulates. This is ironic — taking a CV-protective medication while developing a CV risk factor from reduced nutrition.
Solution: comprehensive vitamin supplementation and regular lab monitoring. Don't let the medication's benefits be undermined by nutritional deficiencies.
Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.
View ResultsMASHdoc_SA said:My reason for being on this is cardiovascular rather than cosmetic, which puts me in a small minority in most of these threads.
MASHdoc_SA said:...cardiovascular risk is just another fad...
I understand the skepticism — we've all seen "miracle" weight loss solutions come and go. But consider what makes GLP-1 agonists different:
This isn't a fad — it's a new drug class supported by the highest level of clinical evidence. The comparison to past fads is understandable but inappropriate.
Moderator note: a couple of off-topic posts removed. Thread quality here is what the rules are for. Keep it up.